SEC Form 4 · accession 0001144204-18-004005
Bionik Laboratories Corp. · BNKL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy A. McCarthy
Officer — See Remarks
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 3:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001508381
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.155 | Jan 24, 2018 | A | 100,000 | A | — | Jan 24, 2028 | Common Stock, par value $0.001 | 100,000 | 100,000 | D |
Explanation of responses
- F1The options vest 33,334 on January 24, 2019, 33,333 on January 24, 2020 and 33,333 on January 24, 2021.
Remarks
Chief Commercialization Officer